Analysts have clear opinions on AVTR.
There are 5 analysts on the Wall offering 12 month price targets for Avantor in the last 3 months. The average price target is $20.23 with a high forecast of $23.00 and a low forecast of $14.90. The average price target represents a 14.49% increase from the last price of $17.67.
Avantor, Inc. (AVTR) is followed by 5 analysts on the street.
Jack Meehan from Barclays rates it a Buy with a target of $21.00.
Similarly, 6 days ago Doug Schenkel of Cowen & Co. Reiterated a Buy with a target of $23.00.
The consensus on the street is null.
What does Avantor, Inc.(AVTR) do ?
Avantor, Inc. is a provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. It sells materials & consumables, equipment & instrumentation and services & specialty procurement. It operates in more than 30 countries and deliver an extensive portfolio of products and services. The company was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.
Avantor, Inc. (AVTR) Insider Trades